Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combretastatin A-4 phosphate with carboplatin and paclitaxel in relapsed platinum-resistant ovarian cancer
ISRCTN57858356Phase 2Completed
- Sponsor
- East and North Hertfordshire NHS Trust
- Start
- Nov 2005
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of fosbretabulin in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC), sponsored by East and North Hertfordshire NHS Trust. Primary endpoints: Tumor response by CT and CA-125 response. Started Nov 2005; status: completed.
02
Drugs
fosbretabulin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on ISRCTN57858356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57858356.